IDH2 antibody (Isocitrate Dehydrogenase 2 (NADP+), Mitochondrial) (AA 354-452)

Details for Product anti-IDH2 Antibody No. ABIN396597, Supplier: Log in to see
Antigen
  • idh2
  • IDH2
  • F6P23.14
  • F6P23_14
  • IDH-II
  • NAD+ DEPENDENT ISOCITRATE DEHYDROGENASE SUBUNIT 2
  • isocitrate dehydrogenase II
  • isocitrate dehydrogenase subunit 2
  • D2HGA2
  • ICD-M
  • IDH
  • IDHM
  • IDP
  • IDPM
  • mNADP-IDH
  • wu:fb33c06
  • wu:fk31e05
  • wu:fq43b01
  • zgc:55485
  • E430004F23
  • IDPm
  • Idh-2
  • isocitrate dehydrogenase 2 (NADP+), mitochondrial
  • Isocitrate dehydrogenase [NAD] regulatory subunit 2
  • idh2
  • IDH2
  • Idh2
Epitope
AA 354-452
15
14
13
9
4
4
3
3
3
2
2
2
1
1
1
1
1
1
1
1
1
Reactivity
Human
95
59
55
10
5
5
5
3
3
2
2
2
2
1
1
1
Host
Mouse
62
19
16
Clonality (Clone)
Monoclonal ()
Conjugate
This IDH2 antibody is un-conjugated
3
3
3
2
2
2
1
1
1
1
1
1
1
1
1
1
1
Application
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), ELISA, Western Blotting (WB)
79
51
35
21
13
12
8
5
4
3
1
1
1
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

Immunogen IDH2 (NP_002159, 354 a.a. ~ 452 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 K
Clone 5F11
Isotype IgG1 kappa
Specificity IDH2 (NP_002159, 354 a.a. ~ 452 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Purification This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
Alternative Name IDH2 (IDH2 Antibody Abstract)
Background Synonyms: Serine protease inhibitor J6, 47 kDa heat shock protein, Collagen-binding protein, Colligin, Serpin H1,Hsp47, Cbp1, Serpinh1
Molecular Weight 50909 DA
Gene ID 12406
NCBI Accession NP_002159
Research Area Metabolism, Cell Structure
Application Notes ELISA ~~ 1ug/ml~3ng/ml Western blot ~~ 1:500~1000 Immunohistochemistry ~~ 1.5ug/ml
Comment

Background: Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. Each NADP(+)-dependent isozyme is a homodimer. The protein encoded by this gene is the NADP(+)-dependent isocitrate dehydrogenase found in the mitochondria. It plays a role in intermediary metabolism and energy production. This protein may tightly associate or interact with the pyruvate dehydrogenase complex.

Restrictions For Research Use only
Buffer PBS with 0.09% (w/v) sodium azide.
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C/-20 °C
Storage Comment Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Expiry Date 6 months
Supplier Images
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) image for anti-IDH2 antibody (Isocitrate Dehydrogenase 2 (NADP+), Mitochondrial) (AA 354-452) (ABIN396597) Immunoperoxidase of monoclonal antibody to IDH2 on formalin-fixed paraffin-embedded h...
Immunohistochemistry (IHC) image for anti-IDH2 antibody (Isocitrate Dehydrogenase 2 (NADP+), Mitochondrial) (AA 354-452) (ABIN396597) anti-Isocitrate Dehydrogenase 2 (NADP+), Mitochondrial (IDH2) (AA 354-452) antibody (Image 2)
Background publications Rocquain, Carbuccia, Trouplin, Raynaud, Murati, Nezri, Tadrist, Olschwang, Vey, Birnbaum, Gelsi-Boyer, Mozziconacci: "Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias." in: BMC cancer, Vol. 10, pp. 401, 2010 (PubMed).

Sellner, Capper, Meyer, Langhans, Hartog, Pfeifer, Serve, Ho, Okun, Krämer, Von Deimling: "Increased levels of 2-hydroxyglutarate in AML patients with IDH1-R132H and IDH2-R140Q mutations." in: European journal of haematology, Vol. 85, Issue 5, pp. 457-9, 2010 (PubMed).

Boissel, Nibourel, Renneville, Gardin, Reman, Contentin, Bordessoule, Pautas, de Revel, Quesnel, Huchette, Philippe, Geffroy, Terre, Thomas, Castaigne, Dombret, Preudhomme: "Prognostic impact of isocitrate dehydrogenase enzyme isoforms 1 and 2 mutations in acute myeloid leukemia: a study by the Acute Leukemia French Association group." in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 28, Issue 23, pp. 3717-23, 2010 (PubMed).

Lopez, Reitman, Solomon, Waldman, Bigner, McLendon, Rosenberg, Samuels, Yan: "IDH1(R132) mutation identified in one human melanoma metastasis, but not correlated with metastases to the brain." in: Biochemical and biophysical research communications, Vol. 398, Issue 3, pp. 585-7, 2010 (PubMed).

Paschka, Schlenk, Gaidzik, Habdank, Krönke, Bullinger, Späth, Kayser, Zucknick, Götze, Horst, Germing, Döhner, Döhner: "IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication." in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 28, Issue 22, pp. 3636-43, 2010 (PubMed).